In vitro quality of amotosalen‐UVA pathogen‐inactivated mini‐pool plasma prepared from whole blood stored overnight
Ravanat, Catherine, Dupuis, Arnaud, Marpaux, Nadine, Naegelen, Christian, Mourey, Guillaume, Isola, Herve, Laforêt, Michel, Morel, Pascal, Gachet, Christian
Published in Vox sanguinis (01.10.2018)
Published in Vox sanguinis (01.10.2018)
Get full text
Journal Article
Homozygous Human TAP Peptide Transporter Mutation in HLA Class I Deficiency
de la Salle, Henri, Hanau, Daniel, Fricker, Dominique, Urlacher, Arlette, Kelly, Adrian, Salamero, Jean, Powis, Stephen H., Donato, Lionel, Bausinger, Huguette, Laforet, Michel, Jeras, Matjaz, Spehner, Danièle, Bieber, Thomas, Falkenrodt, Annie, Cazenave, Jean-Pierre, Trowsdale, John, Tongio, Marie-Marthe
Published in Science (American Association for the Advancement of Science) (08.07.1994)
Published in Science (American Association for the Advancement of Science) (08.07.1994)
Get full text
Journal Article
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period
Cazenave, Jean-Pierre, Isola, Hervé, Waller, Chantal, Mendel, Isabelle, Kientz, Daniel, Laforêt, Michel, Raidot, Jean-Pierre, Kandel, Gérard, Wiesel, Marie-Louise, Corash, Laurence
Published in Transfusion (Philadelphia, Pa.) (01.03.2011)
Published in Transfusion (Philadelphia, Pa.) (01.03.2011)
Get full text
Journal Article
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
van Rhenen, Dick, Gulliksson, Hans, Cazenave, Jean-Pierre, Pamphilon, Derwood, Ljungman, Per, Klüter, Harald, Vermeij, Hans, Kappers-Klunne, Mies, de Greef, Georgine, Laforet, Michel, Lioure, Bruno, Davis, Kathryn, Marblie, Stephane, Mayaudon, Veronique, Flament, Jocelyne, Conlan, Maureen, Lin, Lily, Metzel, Peyton, Buchholz, Don, Corash, Laurence
Published in Blood (15.03.2003)
Published in Blood (15.03.2003)
Get full text
Journal Article
Coagulation Factors in Therapeutic Apheresis Plasma Held for 18 Hours at Ambient Temperature Prior to Pathogen Inactivation (INTERCEPT™)
Cazenave, Jean-Pierre, Isola, Hervé, Wiesel, Marie-Louise, Kientz, Daniel, Laforêt, Michel, Slaedts, Marc, Pinkoski, Linda, Singh, Yasmin, Corash, Laurence
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Coagulation Factor Activity in Therapeutic Plasma Prepared from Whole Blood with Pathogen Inactivation (INTERCEPT™) Treatment
Cazenave, Jean-Pierre, Isola, Hervé, Wiesel, Marie-Louise, Kientz, Daniel, Laforêt, Michel, Pinkoski, Linda, Singh, Yasmin, Corash, Laurence
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Perspective d’inactivation des pathogènes dans les concentrés de globules rouges
Isola, Hervé, Kientz, Daniel, Humbrecht, Catherine, Ravanat, Catherine, Laforet, Michel, Dupuis, Arnaud, Ohlmann, Philippe, Michel, Anita, Cazenave, Jean-Pierre, Gachet, Christian
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01.09.2017)
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01.09.2017)
Get full text
Journal Article
Leukodepletion of platelet concentrates and plasma collected with haemonetics [formula omitted] MCS+ apheresis system. Experience of EFS-Alsace
Kientz, Daniel, Laforêt, Michel, Isola, Hervé, Cazenave, Jean-Pierre
Published in Transfusion and apheresis science (01.08.2001)
Published in Transfusion and apheresis science (01.08.2001)
Get full text
Journal Article
Lack of HLA-A1 and A24 antigenic expression in normal individuals carrying HLA-A01 and A24 alleles
Michel, Laforêt, Anne, Parissiadis, Nadine, Froelich, Marie-Marthe, Tongio
Published in Human immunology (01.04.1996)
Published in Human immunology (01.04.1996)
Get full text
Journal Article